Your Nordic Partner About > Your Nordic partner Signum Life Science has agreed to acquire the Norwegian company Farmastat, with the transaction expected to be completed by the end of August 2025. From now on, the company will be operated by Signum Life Science, a part of the Danish Lægemiddelindustriforeningen(Lif), in close collaboration with Farmastat’s long-time owner, the Norwegian Legemiddelindustrien (LMI). In addition, this step increases our ownership in Swedish Pharma Insights and unites our operations across Denmark, Norway, and Sweden in one organization: Signum Life Science. One Nordic Signum now supports pharma’s commercial success With the acquisition of Farmastat (Norway) and Swedish Pharma Insights (Sweden), the life science industry has gained a strong growth partner for Nordic success. More offerings for data-driven insights and advice are coming your way. What does this mean for you? Your current setup remains unchanged. The services, consulting, and relationships you rely on will continue with the same local teams and high level of service you know and trust. What’s new is the expanded strength behind us: a unified Nordic Signum Life Science with broader data access, enhanced real-world evidence, and a stronger foundation for delivering innovative solutions tailored to your needs. With teams now located in Copenhagen, Oslo, and Stockholm, we’re better positioned than ever to support your business — across markets, data, and borders. Sign up for our newsletter Get the latest news, instant insights, cases, whitepapers and stay up to date. We promise only to send relevant and exciting news. Email * First name * Last name * Company * * Yes, please send me Signum’s newsletter updates, research, and event invitations. Unsubscribe at any time. See our Privacy Policy for details. Get in touch Leave a message and we will get back to you ASAP. Your personal information will be processed according to our Privacy Policy. First Name: Last Name: Company: E-mail: Your Message:
